Verapamil Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Verapamil Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

VERAPAMIL HYDROCHLORIDE DESCRIPTION



Verapamil Hydrochloride





CLINICAL PHARMACOLOGY



Mechanism of action




WARNINGS
WARNINGS




PHARMACOKINETICS AND METABOLISM

PRECAUTIONS
After four weeks of oral dosing (120 mg q.i.d.), verapamil and norverapamil levels were noted in the cerebrospinal fluid with estimated partition coefficient of 0.06 for verapamil and 0.04 for norverapamil.

Hemodynamics and myocardial metabolism
Verapamil reduces afterload and myocardial contractility. Improved left ventricular diastolic function in patients with IHSS and those with coronary heart disease has also been observed with verapamil hydrochloride therapy. In most patients, including those with organic cardiac disease, the negative inotropic action of verapamil is countered by reduction of afterload, and cardiac index is usually not reduced. However, in patients with severe left ventricular dysfunction (e.g., pulmonary wedge pressure above 20 mm Hg or ejection fraction less than 30%), or in patients taking beta-adrenergic blocking agents or other cardiodepressant drugs, deterioration of ventricular function may occur (seeDrug interactions).

Pulmonary function
Verapamil does not induce bronchoconstriction and, hence, does not impair ventilatory function.

INDICATIONS & USAGE








WARNINGSAccessory Bypass Tract)
2. Prophylaxis of repetitive paroxysmal supraventricular tachycardia
Essential Hypertension

VERAPAMIL HYDROCHLORIDE CONTRAINDICATIONS


WARNINGS



WARNINGS


WARNINGS

Heart failure
Drug interactions

Hypotension


Elevated liver enzymes


Accessory bypass tract (Wolff-Parkinson-White or Lown-Ganong-Levine)
CONTRAINDICATIONS

Atrioventricular block


Patients with hypertrophic cardiomyopathy (IHSS)
Drug interactions

PRECAUTIONS

General
OVERDOSAGE

OVERDOSAGE

DRUG INTERACTIONS


























CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY





PREGNANCY



LABOR & DELIVERY



NURSING MOTHERS



PEDIATRIC USE



ANIMAL PHARMACOLOGY & OR TOXICOLOGY



VERAPAMIL HYDROCHLORIDE ADVERSE REACTIONS

WARNINGS
WARNINGS









Treatment of acute cardiovascular adverse reactions


OVERDOSAGE




DOSAGE & ADMINISTRATION



Angina


Arrhythmias
PRECAUTIONS

Essential Hypertension


HOW SUPPLIED








STORAGE AND HANDLING





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Verapamil Hydrochloride

Verapamil Hydrochloride

Verapamil Hydrochloride

Verapamil Hydrochloride TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-459(NDC:0591-0343)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
VERAPAMIL HYDROCHLORIDE VERAPAMIL 80 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
STARCH, CORN
MAGNESIUM STEARATE
cellulose, microcrystalline
POLACRILIN POTASSIUM
polyethylene glycol 400
hydroxypropyl cellulose
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
white 9 mm WATSON;343 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-459-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA070995 2011-08-08


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.